Business
Announcement on Reply to the Information Disclosure Regulatory Letter on the Report for Q3 2024
Announcement on Reply to the Information Disclosure Regulatory Letter on the Report for Q3 2024
About this update from Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd Class A
Announcement on Reply to the Information Disclosure Regulatory Letter on the Report for Q3 2024The abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment